The impact of filgotinib on patient-reported outcomes and health-related quality of life for patients with active rheumatoid arthritis: a post hoc analysis of Phase 3 studies.

Clifton O BinghamDavid WalkerPeter NashSusan J LeeLei YeHao HuJavaria Mona KhalidBernard Combe

Published in: Arthritis research & therapy (2022)

ClinicalTrials.gov , FINCH 1, NCT02889796 , first posted September 7, 2016; FINCH 2, NCT02873936 , first posted August 22, 2016, retrospectively registered; FINCH 3, NCT02886728 , first posted September 1, 2016, retrospectively registered.

Keyphrases

patient reported outcomes
rheumatoid arthritis
disease activity
case control